You are here

CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement

--Expansion of Collaboration to Focus on the Development of Novel Capsids for Additional Applications-- --Expansion of Collaboration to Focus on the Development of Novel Capsids for Additional Applications--
Tuesday, February 19, 2019 - 07:00